Endocyte (ECYT) Surges on Deal with Merck
Shares of Endocyte, Inc. (NASDAQ:ECYT) are surging over 103% in morning trade after the company announced that it has entered into an agreement with drug giant Merck (NYSE:MRK) to develop and commercialize Endocyte’s novel...